ATP disodium letsoai CAS 987-65-5

CAS:987-65-5

Bohloeki:99%

Foromo ea molek'hule:C10H17N5NaO13P3

Boima ba Molek'hule:531.18

EINECS:213-579-1

Nako ea polokelo:lilemo tse 2

Mantsoe a tšoanang:ADENOSINETRIPHOSPHATEDISODIUM; ADENOSINETRIPHOSPHATE,DISODIUMSALT; ADENYLPYROPHOSPHORICACIDDISODIUMSALT; ADENOSINE-5′-TRIPHOSPHATEHYDRATEDISODIUMSALT; ADENOSINE-5′-TRIPHOSPHATENA2-LETSWAI; ADENOSINE-5′-TRIPHOSPHORICACID,DISODIUM; ADENOSINE-5′-TRIPHOSPHORICACIDDISODIUMDIHYDROGENSALT; ADENOSINE5′-TRIPHOSPHORICACIDDISODIUMSALT

Tlohela Molaetsa wa Hao

Lintlha tsa Sehlahisoa

Khoasolla

Li-tag tsa Sehlahisoa

ATP disodium letsoai CAS 987-65-5 ke eng?

ATP disodium letsoai ke metabolite ea adenosine, e leng multifunctional nucleoside triphosphate e sebelisoang e le coenzyme bakeng sa phetiso ea matla a intracellular liseleng. E tsamaisa matla a lik'hemik'hale ka har'a lisele bakeng sa metabolism. Letsoai la ATP disodium le sebelisetsoa ho etsa li-analogue tsa deoxyadenosine diphosphate tse fetotsoeng ka ribose e le li-receptor tsa P2Y1.

Tlhaloso

Ponahalo	Phofo e tšoeu kapa phofo e tšoeu kapa phofo ea kristale, hygroscopic.
Boholo ba likaroloana	95% e feta 80 mesh.
pH	2.5 ho isa ho 3.5
Solubility	E qhibilihang ka metsing; ha e qhibilihe ka har'a ethanol le ether.
Oder	Oderless
Likahare tsa metsi	6.0%~12.0%
Chloride	≤0.05%
Letsoai la tšepe	≤0.001%
Litšepe tse boima	≤0.001%
Ketapele	≤2.0ppm
Arsenic	≤1.0ppm

Kopo

1. Litšebeliso tsa lipatlisiso tsa indasteri le tsa mahlale
(1) Lisebelisuoa tse tala tsa litlolo: li kenyelelitsoe lihlahisoa tsa tlhokomelo ea letlalo tse thibelang botsofali, li ka ntlafatsa letlalo le khanyang ka ho kenya matla metabolism ea lisele.
(2) Li-additives tsa lijo: tse sebelisoang e le sehlomathisi sa phepo ho lino tsa lipapali le lijo tse sebetsang ho tlatsa matla ka potlako.
2. Libaka tsa phekolo ea meriana
(1) Mafu a tsamaiso ea methapo ea pelo: e sebelisetsoang ho hloleha ha pelo, myocarditis, infarction ea myocardial le cerebral arteriosclerosis, joalo-joalo, ka ho ntlafatsa metabolism ea matla a myocardial le ho atoloha ha methapo ea mali (ho eketsa phallo ea mali ka hoo e ka bang 30%), ho imolla matšoao a myocardial ischemia. Mohlala, ho bakuli ba nang le acute myocardial infarction, ATP disodium e ka khutsufatsa nako ea hoetla ea karolo ea ST mme ea fokotsa boleng ba tlhoro ea spectrum ea enzyme ea myocardial.
(2) Mafu a tsamaiso ea methapo: phekolo e thusang ea sequelae ea ho tsoa ha mali bokong, tšenyo ea boko le atrophy ea mesifa e tsoelang pele, ka ho kenella ka mokoallo oa mali-boko (permeability ke hoo e ka bang 65%), ho khothalletsa ho lokisoa ha lera la methapo ea kutlo le ho tsosolosoa ha methapo ea kutlo, le ho ntlafatsa lebelo la ho tsamaisa methapo ea kutlo.
(3) Mafu a Metabolic: Ha ho phekoloa lefu la sebete le lefu la sebete, ATP disodium e ka ntlafatsa mosebetsi oa mitochondrial oa hepatocyte, ho potlakisa ho lokisoa ha hepatocyte, le ho fokotsa maemo a ALT le AST; e boetse e na le phello e thusang ea ntlafatso ho mathata a lefu la tsoekere (joalo ka peripheral neuropathy).
3. Libaka tsa kopo tse hlahang
(1) Mokhoa oa ho fana ka lithethefatsi o lebisitsoeng: ATP disodium e ka sebelisoa e le mochine o tsamaisang thepa, o kopantsoe le liposomes kapa nanoparticles, ho finyella ho fana ka lithethefatsi tse lebisitsoeng ka endocytosis ea receptor. Mohlala, kalafong ea tumor, li-nanomedicine tse fetotsoeng tsa ATP li ka ntlafatsa katleho e ikhethileng ea litlhare tsa chemotherapy liseleng tsa mofetše.
(2) Tloaelo ea lisele le li-biopharmaceuticals: E le karolo ea bohlokoa ea setso sa setso sa lisele, ATP disodium e ka khothalletsa kholo le protheine polelo ea lisele tsa CHO, lisele tsa HEK293, joalo-joalo, 'me e sebelisoa haholo tlhahiso ea antibody ea monoclonal.